TRDA

NASDAQStock

Entrada Therapeutics, Inc.

$12.60-0.39 (-2.97%)

52-Week Range

$5.02
$13.50

Key Stats

Market Cap

482.2M

P/E Ratio

Dividend Yield

Beta

-0.12

Volume

95.7K

Avg Volume

258.2K

Performance

1M

+19.30%

3M

+17.68%

6M

+153.52%

YTD

+29.15%

1Y

+20.07%

3Y

-7.94%

5Y

-45.80%

Price Chart

ETF Exposure

TRDA is held by 54 ETFs

ETFFund NameWeight
IBRNiShares Neuroscience and Healthcare ETF0.38%
HAPSHarbor Human Capital Factor US Small Cap ETF (HAPS)0.17%
FSMLFranklin Small Cap Enhanced ETF0.13%
IWCiShares Micro-Cap ETF0.08%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.06%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
AVSCAvantis U.S. Small Cap Equity ETF0.04%
BIBProShares - Ultra Nasdaq Biotechnology0.03%
IWNiShares Russell 2000 Value ETF0.03%
IBBiShares Biotechnology ETF0.03%
NUSCNuveen ESG Small-Cap0.02%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.02%
VTWVVanguard Russell 2000 Value ETF0.02%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.01%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.01%
IWMiShares Russell 2000 ETF0.01%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
VTWOVanguard Russell 2000 ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
UWMProShares - Ultra Russell20000.01%
DFASDimensional - US Small Cap ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
URTYProShares - UltraPro Russell20000.01%
DFSVDimensional - US Small Cap Value ETF0.01%
SMMDiShares Russell 2500 ETF0.00%
VHTVanguard Health Care ETF0.00%
VXFVanguard Extended Market ETF0.00%
AVSUAvantis Responsible U.S. Equity ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
DFAUDimensional - US Core Equity Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
Page 1 of 2Next

About TRDA ETF Exposure

Entrada Therapeutics, Inc. (TRDA) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 482.2M, TRDA is a widely held institutional stock. The stock currently trades at $12.60. Investors can gain exposure to TRDA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TRDA, sorted by portfolio weight.